Benutzer: Gast  Login
Titel:

Treatment landscape of advanced breast cancer patients with hormone receptor positive HER2 negative tumors - Data from the German PRAEGNANT breast cancer registry.

Dokumenttyp:
Article; Journal Article
Autor(en):
Hartkopf, Andreas D; Huober, Jens; Volz, Bernhard; Nabieva, Naiba; Taran, Florin-Andrei; Schwitulla, Judith; Overkamp, Friedrich; Kolberg, Hans-Christian; Hadji, Peyman; Tesch, Hans; Häberle, Lothar; Ettl, Johannes; Lux, Michael P; Lüftner, Diana; Wallwiener, Markus; Müller, Volkmar; Beckmann, Matthias W; Belleville, Erik; Wimberger, Pauline; Hielscher, Carsten; Geberth, Matthias; Fersis, Nikos; Abenhardt, Wolfgang; Kurbacher, Christian; Wuerstlein, Rachel; Thomssen, Christoph; Untch, Michael; F...     »
Abstract:
PURPOSE: This study describes comprehensive data from a breast cancer registry concerning the use of endocrine treatment (ET) and chemotherapy in the first, second and higher therapy lines in hormone receptor (HR) positive, HER2 negative metastatic breast cancer (MBC). METHODS: The PRAEGNANT study is a real-time registry for patients with MBC. Therapies were categorized into the following categories: chemotherapy, aromatase inhibitor (AI), tamoxifen, fulvestrant, or everolimus plus ET and report...     »
Zeitschriftentitel:
Breast
Jahr:
2018
Band / Volume:
37
Seitenangaben Beitrag:
42-51
Volltext / DOI:
doi:10.1016/j.breast.2017.10.002
PubMed:
http://view.ncbi.nlm.nih.gov/pubmed/29100043
Print-ISSN:
0960-9776
TUM Einrichtung:
Frauenklinik und Poliklinik
 BibTeX